# OnCo record etoposide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/etoposide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "etoposide" ;
  schema:name "Etoposide"@en ;
  schema:description "Etoposide is a chemotherapy from the mayapple plant, essential to curing testicular cancer (BEP), treating small-cell lung cancer, lymphomas, childhood sarcomas and leukaemias, and used in transplant conditioning."@en ;
  schema:url <https://onco.cc/drugs/etoposide/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Etoposide> ;
  owl:sameAs <http://www.wikidata.org/entity/Q418817> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=etoposide> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "generic", "who-essential" ;
  onco:modality "Topoisomerase II inhibitor (podophyllotoxin derivative)" ;
  schema:alternateName "VePesid / Etopophos / Toposar" ;
  onco:approval "US 1983: Refractory testicular tumours; small-cell lung cancer (1986)" ;
  onco:cancers <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/wilms-tumor/>, <https://onco.cc/cancers/retinoblastoma/>, <https://onco.cc/cancers/gestational-trophoblastic/>, <https://onco.cc/cancers/adrenocortical/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/cns-germ-cell-tumours/>, <https://onco.cc/cancers/high-risk-gtn/>, <https://onco.cc/cancers/placental-site-trophoblastic-tumour/>, <https://onco.cc/cancers/advanced-adrenocortical-carcinoma/>, <https://onco.cc/cancers/esthesioneuroblastoma/>, <https://onco.cc/cancers/sinonasal-undifferentiated-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/topoisomerase-inhibitors/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:targets <https://onco.cc/targets/kmt2a/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/euramos-1/>, <https://onco.cc/trials/nct06712355/>, <https://onco.cc/trials/nct07625644/>, <https://onco.cc/trials/nct07502300/>, <https://onco.cc/trials/nct06564844/>, <https://onco.cc/trials/nct07005128/>, <https://onco.cc/trials/nct06230224/>, <https://onco.cc/trials/nct07472517/>, <https://onco.cc/trials/nct05652686/>, <https://onco.cc/trials/nct04745689/>, <https://onco.cc/trials/nct06030258/>, <https://onco.cc/trials/nct07296809/>, <https://onco.cc/trials/nct07245446/>, <https://onco.cc/trials/nct05533775/>, <https://onco.cc/trials/nct07730515/>, <https://onco.cc/trials/nct07155174/>, <https://onco.cc/trials/nct06449209/>, <https://onco.cc/trials/nct07227597/>, <https://onco.cc/trials/nct05224141/>, <https://onco.cc/trials/nct05844150/>, <https://onco.cc/trials/nct04665856/>, <https://onco.cc/trials/nct07268040/>, <https://onco.cc/trials/nct07544654/>, <https://onco.cc/trials/nct05566041/>, <https://onco.cc/trials/nct03182244/>, <https://onco.cc/trials/nct01064466/>, <https://onco.cc/trials/nct06741644/>, <https://onco.cc/trials/nct03793478/>, <https://onco.cc/trials/nct04380636/> ;
  onco:people <https://onco.cc/people/lance-armstrong/> .